Wang, Yaning <br/><br/>
Leveraging prior quantitative knowledge to guide drug development decisions and regulatory science recommendations: impact of FDA pharmacometrics during 2004-2006.  [electronic resource] 

 -  Journal of clinical pharmacology  Feb 2008 
 - 146-56 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0091-2700 
<br/><br/><label>Standard No.: </label>10.1177/0091270007311111  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Clinical Trials as Topic--methods<br/>Decision Making<br/>Drug Approval--legislation & jurisprudence<br/>Drug Industry--legislation & jurisprudence<br/>Government Regulation<br/>Guidelines as Topic<br/>Humans<br/>Investigational New Drug Application--legislation & jurisprudence<br/>Legislation, Drug--standards<br/>Organizational Objectives<br/>Time Factors<br/>United States<br/>United States Food and Drug Administration--legislation & jurisprudence